SCHEMBL17437482

SCHEMBL17437482

Nc1ncnn1-c1nc2cncc(-c3ccccc3Cl)c2n1-c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CYP1A2 P05177 7/20 0.32
▸ CYP3A4 P08684 5/20 0.32
▸ CYP2C9 P11712 4/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ HSD17B10 Q99714 3/20 0.32
▸ LIMK1 P53667 1/20 0.32
▸ NPC1 O15118 3/20 0.32
▸ RAB9A P51151 3/20 0.32
▸ CYP2C19 P33261 5/20 0.32
▸ USP2 O75604 3/20 0.32
▸ TSHR P16473 3/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ HIF1A Q16665 2/20 0.32
▸ CYP2D6 P10635 2/20 0.32
▸ CNR1 P21554 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437382 0.90 USP2 (0.36) MEN1KMT2AKDM4ECYP1A2CYP3A4
SCHEMBL17437313 0.88 MAPT (0.34) MEN1KMT2AKDM4EMAPTCYP1A2
SCHEMBL17437310 0.85 CYP1A2 (0.40) CYP1A2CYP3A4ALDH1A1HSD17B10LIMK1
SCHEMBL17437506 0.82 RPS6KA5 (0.34) KDM4ECYP1A2CYP3A4HSD17B10LIMK1
SCHEMBL17437486 0.81 SLC9A1 (0.33) HPGDCYP1A2CYP3A4ALDH1A1HSD17B10
SCHEMBL17437328 0.81 CYP1A2 (0.35) MEN1KMT2AKDM4EMAPTCYP1A2
SCHEMBL17437480 0.81 KDM4E (0.34) KDM4EMAPTCYP1A2CYP3A4ALDH1A1
SCHEMBL17437378 0.81 TLR8 (0.35) KDM4ECYP1A2CYP3A4HSD17B10LIMK1
SCHEMBL17437317 0.78 ALDH1A1 (0.33) MEN1KMT2AKDM4EMAPTCYP1A2
SCHEMBL17437386 0.75 RPS6KA5 (0.49) MEN1KMT2ACYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 — — US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 — — US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 MEN1 1026/4885KMT2A 2059/4885KDM4E 1452/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 MEN1 1026/4885KMT2A 2059/4885KDM4E 1452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback